{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:27:32Z","timestamp":1794713252629,"version":"4.9.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS085131"],"award-info":[{"award-number":["R01NS085131"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-15-1-0679"],"award-info":[{"award-number":["W81XWH-15-1-0679"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91324-1","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T03:23:57Z","timestamp":1740972237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis\/chronic fatigue syndroome (ME\/CFS)"],"prefix":"10.1038","volume":"15","author":[{"given":"James N.","family":"Baraniuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"12","key":"91324_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda, K. et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 121(12), 953\u2013959 (1994).","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"91324_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/jcp.2006.042754","volume":"60","author":"BM Carruthers","year":"2007","unstructured":"Carruthers, B. M. Definitions and aetiology of myalgic encephalomyelitis: How the Canadian consensus clinical definition of myalgic encephalomyelitis works. J. Clin. Pathol. 60(2), 117\u2013119 (2007).","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"91324_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers, B. M. et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 270(4), 327\u2013338 (2011).","journal-title":"J. Intern. Med."},{"key":"91324_CR4","unstructured":"Beyond myalgic encephalomyelitis\/chronic fatigue syndrome redefining an illness [Internet]. 2015 [cited 2022 Nov 16]. Available from: https:\/\/nap.nationalacademies.org\/read\/19012\/chapter\/1"},{"issue":"18","key":"91324_CR5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/archinte.159.18.2129","volume":"159","author":"LA Jason","year":"1999","unstructured":"Jason, L. A. et al. A community-based study of chronic fatigue syndrome. Arch. Intern. Med. 159(18), 2129\u20132137 (1999).","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"91324_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/archinte.163.13.1530","volume":"163","author":"M Reyes","year":"2003","unstructured":"Reyes, M. et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch. Intern. Med. 163(13), 1530\u20131536 (2003).","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"91324_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7547-9-1","volume":"9","author":"JMS Lin","year":"2011","unstructured":"Lin, J. M. S. et al. The economic impact of chronic fatigue syndrome in Georgia: Direct and indirect costs. Cost Eff. Resour. Alloc. 9(1), 1 (2011).","journal-title":"Cost Eff. Resour. Alloc."},{"key":"91324_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fped.2019.00185","volume":"7","author":"J Bae","year":"2019","unstructured":"Bae, J. & Lin, J. M. S. Healthcare utilization in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Analysis of US ambulatory healthcare data, 2000\u20132009. Front. Pediatr. 7, 185 (2019).","journal-title":"Front. Pediatr."},{"key":"91324_CR9","first-page":"1","volume":"488","author":"A Vahratian","year":"2023","unstructured":"Vahratian, A., Lin, J. M. S., Bertolli, J. & Unger, E. R. Myalgic encephalomyelitis\/chronic fatigue syndrome in adults: United States, 2021\u20132022. NCHS Data Brief. 488, 1\u20138 (2023).","journal-title":"NCHS Data Brief."},{"issue":"10","key":"91324_CR10","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3390\/diagnostics12102540","volume":"12","author":"A Ghali","year":"2022","unstructured":"Ghali, A. et al. Factors influencing the prognosis of patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Diagnostics (Basel) 12(10), 2540 (2022).","journal-title":"Diagnostics (Basel)"},{"key":"91324_CR11","volume-title":"Long-term health effects of COVID-19","year":"2024","unstructured":"Volberding, P. A. et al. (eds) Long-term health effects of COVID-19 (National Academies Press, 2024)."},{"issue":"1","key":"91324_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2023-000529","volume":"6","author":"B Stussman","year":"2024","unstructured":"Stussman, B. et al. Mixed methods system for the assessment of post-exertional malaise in myalgic encephalomyelitis\/chronic fatigue syndrome: an exploratory study. BMJ Neurol. Open 6(1), e000529 (2024).","journal-title":"BMJ Neurol. Open"},{"issue":"1","key":"91324_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/10852352.2014.973239","volume":"43","author":"LA Jason","year":"2015","unstructured":"Jason, L. A., Evans, M., So, S., Scott, J. & Brown, A. Problems in defining post-exertional malaise. J. Prev. Interv. Commun. 43(1), 20\u201331 (2015).","journal-title":"J. Prev. Interv. Commun."},{"issue":"1","key":"91324_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/metabo10010034","volume":"10","author":"A Germain","year":"2020","unstructured":"Germain, A., Barupal, D. K., Levine, S. M. & Hanson, M. R. Comprehensive circulatory metabolomics in ME\/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites 10(1), 34 (2020).","journal-title":"Metabolites"},{"key":"91324_CR15","doi-asserted-by":"crossref","unstructured":"Hoel, F., Hoel, A., Pettersen, I. K., Rekeland, I. G., Risa, K. & Alme, K., et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome. JCI Insight. 6(16), (2021).","DOI":"10.1172\/jci.insight.149217"},{"key":"91324_CR16","doi-asserted-by":"crossref","unstructured":"Che, X., Brydges, C. R., Yu, Y., Price, A., Joshi, S. & Roy, A., et al. Evidence for peroxisomal dysfunction and dysregulation of the CDP-choline pathway in myalgic encephalomyelitis\/chronic fatigue syndrome. medRxiv, (2022).","DOI":"10.1101\/2021.06.14.21258895"},{"issue":"37","key":"91324_CR17","doi-asserted-by":"publisher","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","volume":"113","author":"RK Naviaux","year":"2016","unstructured":"Naviaux, R. K. et al. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA 113(37), E5472\u2013E5480 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"91324_CR18","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.3390\/ijms24043685","volume":"24","author":"KA Glass","year":"2023","unstructured":"Glass, K. A., Germain, A., Huang, Y. V. & Hanson, M. R. Urine metabolomics exposes anomalous recovery after maximal exertion in female ME\/CFS patients. Int. J. Mol. Sci. 24(4), 3685 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"91324_CR19","unstructured":"https:\/\/www.metabolomicsworkbench.org\/data\/DRCCMetadata.php?Mode=Study&StudyID=ST000910&StudyType=MS&ResultType=1. 2018."},{"issue":"1","key":"91324_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41467-024-45107-3","volume":"15","author":"B Walitt","year":"2024","unstructured":"Walitt, B. et al. Deep phenotyping of post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome. Nat. Commun. 15(1), 907 (2024).","journal-title":"Nat. Commun."},{"issue":"7","key":"91324_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200509R","volume":"36","author":"K Li","year":"2022","unstructured":"Li, K. et al. Cerebrospinal fluid and plasma metabolomics of acute endurance exercise. FASEB J. 36(7), e22408 (2022).","journal-title":"FASEB J."},{"issue":"10","key":"91324_CR22","first-page":"3254","volume":"10","author":"RS Garner","year":"2018","unstructured":"Garner, R. S., Rayhan, R. U. & Baraniuk, J. N. Verification of exercise-induced transient postural tachycardia phenotype in Gulf War Illness. Am J Transl Res. 10(10), 3254\u20133264 (2018).","journal-title":"Am J Transl Res."},{"issue":"2","key":"91324_CR23","doi-asserted-by":"publisher","first-page":"fcaa070","DOI":"10.1093\/braincomms\/fcaa070","volume":"2","author":"SD Washington","year":"2020","unstructured":"Washington, S. D. et al. Exercise alters brain activation in Gulf War illness and myalgic encephalomyelitis\/chronic fatigue syndrome. Brain Commun. 2(2), fcaa070 (2020).","journal-title":"Brain Commun."},{"issue":"1","key":"91324_CR24","doi-asserted-by":"publisher","first-page":"15338","DOI":"10.1038\/s41598-017-15383-9","volume":"7","author":"JN Baraniuk","year":"2017","unstructured":"Baraniuk, J. N. & Shivapurkar, N. Exercise - induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, chronic fatigue syndrome and sedentary control subjects. Sci. Rep. 7(1), 15338 (2017).","journal-title":"Sci. Rep."},{"key":"91324_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.748426","volume":"15","author":"RU Rayhan","year":"2021","unstructured":"Rayhan, R. U. & Baraniuk, J. N. Submaximal exercise provokes increased activation of the anterior default mode network during the resting state as a biomarker of postexertional malaise in myalgic encephalomyelitis\/chronic fatigue syndrome. Front. Neurosci. 15, 748426 (2021).","journal-title":"Front. Neurosci."},{"issue":"1","key":"91324_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13293-022-00440-4","volume":"13","author":"M Costanzo","year":"2022","unstructured":"Costanzo, M. et al. Sex differences in the human metabolome. Biol. Sex Differ. 13(1), 30 (2022).","journal-title":"Biol. Sex Differ."},{"issue":"21","key":"91324_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89376","volume":"1","author":"\u00d8 Fluge","year":"2016","unstructured":"Fluge, \u00d8. et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome. JCI Insight 1(21), e89376 (2016).","journal-title":"JCI Insight"},{"issue":"1","key":"91324_CR28","first-page":"53","volume":"5","author":"JN Baraniuk","year":"2013","unstructured":"Baraniuk, J. N. et al. A chronic fatigue syndrome (CFS) severity score based on case designation criteria. Am. J. Transl. Res. 5(1), 53\u201368 (2013).","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"91324_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe, F. et al. The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 33(2), 160\u2013172 (1990).","journal-title":"Arthritis Rheum."},{"issue":"5","key":"91324_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 62(5), 600\u2013610 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"10","key":"91324_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601273","volume":"2","author":"J Meiser","year":"2016","unstructured":"Meiser, J. et al. Serine one-carbon catabolism with formate overflow. Sci. Adv. 2(10), e1601273 (2016).","journal-title":"Sci. Adv."},{"issue":"2","key":"91324_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41389-020-0200-9","volume":"9","author":"E Zhao","year":"2020","unstructured":"Zhao, E., Hou, J. & Cui, H. Serine-glycine-one-carbon metabolism: Vulnerabilities in MYCN-amplified neuroblastoma. Oncogenesis 9(2), 14 (2020).","journal-title":"Oncogenesis"},{"issue":"1","key":"91324_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40364-023-00487-4","volume":"11","author":"W Sun","year":"2023","unstructured":"Sun, W. et al. Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers. Biomark Res. 11(1), 48 (2023).","journal-title":"Biomark Res."},{"issue":"1","key":"91324_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tra.12230","volume":"16","author":"JE Vance","year":"2015","unstructured":"Vance, J. E. Phospholipid synthesis and transport in mammalian cells. Traffic 16(1), 1\u201318 (2015).","journal-title":"Traffic"},{"key":"91324_CR35","doi-asserted-by":"crossref","unstructured":"Reus, L. M., Boltz, T., Francia, M., Bot, M., Ramesh, N. & Koromina, M., et al. Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes. bioRxiv, (2023).","DOI":"10.1101\/2023.09.26.559021"},{"issue":"9","key":"91324_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.184","volume":"6","author":"F Ciregia","year":"2016","unstructured":"Ciregia, F. et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl. Psychiatry 6(9), e904 (2016).","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"91324_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun, A. A., Lukey, M. J., Cerione, R. A. & Locasale, J. W. Glutamine metabolism in cancer: Understanding the heterogeneity. Trends Cancer 3(3), 169\u2013180 (2017).","journal-title":"Trends Cancer"},{"issue":"1","key":"91324_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12967-019-1935-y","volume":"17","author":"R Garner","year":"2019","unstructured":"Garner, R. & Baraniuk, J. N. Orthostatic intolerance in chronic fatigue syndrome. J. Transl. Med. 17(1), 185 (2019).","journal-title":"J. Transl. Med."},{"key":"91324_CR39","doi-asserted-by":"crossref","unstructured":"Germain, A., Giloteaux, L., Moore, G. E., Levine, S. M., Chia, J. K. & Keller, B. A., et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis\/chronic fatigue syndrome. JCI Insight. 7(9), (2022).","DOI":"10.1172\/jci.insight.157621"},{"issue":"1","key":"91324_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12403","volume":"13","author":"L Giloteaux","year":"2024","unstructured":"Giloteaux, L. et al. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis\/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. J. Extracell Vesicles 13(1), e12403 (2024).","journal-title":"J. Extracell Vesicles"},{"issue":"1","key":"91324_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s42003-020-01583-z","volume":"4","author":"DJ Panyard","year":"2021","unstructured":"Panyard, D. J. et al. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations. Commun. Biol. 4(1), 63 (2021).","journal-title":"Commun. Biol."},{"key":"91324_CR42","unstructured":"https:\/\/biocrates.com\/absoluteidq-p180-kit\/."},{"issue":"2","key":"91324_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/metabo11020126","volume":"11","author":"H Carlsson","year":"2021","unstructured":"Carlsson, H. et al. Metabolomics of cerebrospinal fluid from healthy subjects reveal metabolites associated with ageing. Metabolites 11(2), 126 (2021).","journal-title":"Metabolites"},{"issue":"4","key":"91324_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/gerona\/glab212","volume":"77","author":"N Hwangbo","year":"2022","unstructured":"Hwangbo, N. et al. A metabolomic aging clock using human cerebrospinal fluid. J. Gerontol. A Biol. Sci. Med. Sci. 77(4), 744\u2013754 (2022).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"91324_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12877-023-03939-6","volume":"23","author":"FC Liu","year":"2023","unstructured":"Liu, F. C. et al. Exploring the aging process of cognitively healthy adults by analyzing cerebrospinal fluid metabolomics using liquid chromatography-tandem mass spectrometry. BMC Geriatr. 23(1), 217 (2023).","journal-title":"BMC Geriatr."},{"issue":"1","key":"91324_CR46","doi-asserted-by":"publisher","first-page":"18822","DOI":"10.1038\/s41598-021-97491-1","volume":"11","author":"K Peters","year":"2021","unstructured":"Peters, K. et al. Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid. Sci. Rep. 11(1), 18822 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"91324_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11306-020-01757-0","volume":"17","author":"ZW Reavis","year":"2021","unstructured":"Reavis, Z. W. et al. Sex and race differences of cerebrospinal fluid metabolites in healthy individuals. Metabolomics 17(2), 13 (2021).","journal-title":"Metabolomics"},{"issue":"1","key":"91324_CR48","doi-asserted-by":"publisher","first-page":"13752","DOI":"10.1038\/s41598-023-39737-8","volume":"13","author":"K Borkowski","year":"2023","unstructured":"Borkowski, K. et al. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. Sci. Rep. 13(1), 13752 (2023).","journal-title":"Sci. Rep."},{"issue":"Suppl 2","key":"91324_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato, D. J., Quan, N. & Godbout, J. P. Neuroinflammation: The devil is in the details. J. Neurochem. 139(Suppl 2), 136\u2013153 (2016).","journal-title":"J. Neurochem."},{"key":"91324_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbi.2023.10.016","volume":"115","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection. Brain Behav. Immun. 115, 209\u2013222 (2024).","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"91324_CR51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12967-024-05422-1","volume":"22","author":"F Neu","year":"2024","unstructured":"Neu, F. et al. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens. J. Transl. Med. 22(1), 620 (2024).","journal-title":"J. Transl. Med."},{"key":"91324_CR52","doi-asserted-by":"publisher","first-page":"1403312","DOI":"10.3389\/fneur.2024.1403312","volume":"15","author":"ON Plaatjie","year":"2024","unstructured":"Plaatjie, O. N., van Furth, A. M. T., van der Kuip, M. & Mason, S. LC-MS metabolomics and lipidomics in cerebrospinal fluid from viral and bacterial CNS infections: A review. Front. Neurol. 15, 1403312 (2024).","journal-title":"Front. Neurol."},{"issue":"12","key":"91324_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007045","volume":"12","author":"CD French","year":"2018","unstructured":"French, C. D. et al. NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system. PLoS Negl. Trop Dis. 12(12), e0007045 (2018).","journal-title":"PLoS Negl. Trop Dis."},{"issue":"2","key":"91324_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijms20020337","volume":"20","author":"D Ratuszny","year":"2019","unstructured":"Ratuszny, D. et al. Identification of cerebrospinal fluid metabolites as biomarkers for enterovirus meningitis. Int. J. Mol. Sci. 20(2), 337 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"91324_CR55","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","volume":"28","author":"E Cassol","year":"2014","unstructured":"Cassol, E., Misra, V., Dutta, A., Morgello, S. & Gabuzda, D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS 28(11), 1579\u20131591 (2014).","journal-title":"AIDS"},{"issue":"8","key":"91324_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1318","volume":"10","author":"J Yan","year":"2021","unstructured":"Yan, J., Kuzhiumparambil, U., Bandodkar, S., Dale, R. C. & Fu, S. Cerebrospinal fluid metabolomics: Detection of neuroinflammation in human central nervous system disease. Clin. Transl. Immunol. 10(8), e1318 (2021).","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"91324_CR57","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s12967-023-04637-y","volume":"21","author":"A Al-Mekhlafi","year":"2023","unstructured":"Al-Mekhlafi, A. et al. Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation. J. Transl. Med. 21(1), 776 (2023).","journal-title":"J. Transl. Med."},{"issue":"4","key":"91324_CR58","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/epi.17899","volume":"65","author":"A Hanin","year":"2024","unstructured":"Hanin, A. et al. Metabolomic changes in adults with status epilepticus: A human case-control study. Epilepsia 65(4), 929\u2013943 (2024).","journal-title":"Epilepsia"},{"issue":"8","key":"91324_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3070","volume":"13","author":"L Xu","year":"2023","unstructured":"Xu, L. et al. Cerebrospinal fluid metabolite alterations in patients with different etiologies, diagnoses, and prognoses of disorders of consciousness. Brain Behav. 13(8), e3070 (2023).","journal-title":"Brain Behav."},{"issue":"9","key":"91324_CR60","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3390\/biomedicines11092525","volume":"11","author":"E B\u00e4ckryd","year":"2023","unstructured":"B\u00e4ckryd, E., Thordeman, K., Gerdle, B. & Ghafouri, B. Cerebrospinal fluid metabolomics identified ongoing analgesic medication in neuropathic pain patients. Biomedicines 11(9), 2525 (2023).","journal-title":"Biomedicines"},{"issue":"1","key":"91324_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10194-016-0711-0","volume":"18","author":"CF Gasparini","year":"2017","unstructured":"Gasparini, C. F., Smith, R. A. & Griffiths, L. R. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J. Headache Pain 18(1), 20 (2017).","journal-title":"J. Headache Pain"},{"issue":"3","key":"91324_CR62","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1039\/D0MO00186D","volume":"17","author":"SK Byeon","year":"2021","unstructured":"Byeon, S. K. et al. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer\u2019s disease. Mol. Omics 17(3), 454\u2013463 (2021).","journal-title":"Mol. Omics"},{"issue":"1","key":"91324_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12590","volume":"135","author":"AD Andersen","year":"2017","unstructured":"Andersen, A. D., Binzer, M., Stenager, E. & Gramsbergen, J. B. Cerebrospinal fluid biomarkers for Parkinson\u2019s disease - A systematic review. Acta Neurol. Scand 135(1), 34\u201356 (2017).","journal-title":"Acta Neurol. Scand"},{"issue":"1","key":"91324_CR64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12974-024-03218-0","volume":"21","author":"C Otto","year":"2024","unstructured":"Otto, C. et al. Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases. J. Neuroinflammation 21(1), 234 (2024).","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"91324_CR65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells8020084","volume":"8","author":"S Herman","year":"2019","unstructured":"Herman, S., \u00c5kerfeldt, T., Spjuth, O., Burman, J. & Kultima, K. Biochemical differences in cerebrospinal fluid between secondary progressive and relapsing\u2212remitting multiple sclerosis. Cells 8(2), 84 (2019).","journal-title":"Cells"},{"key":"91324_CR66","doi-asserted-by":"crossref","unstructured":"Xie, K., Sun, Y., Li, X., Yang, S., Wang, M. & Zhang, Y., et al. Biomarkers and pathways in autism spectrum disorder: An individual meta-analysis based on proteomic and metabolomic data. Eur. Arch. Psychiatry Clin. Neurosci., (2024).","DOI":"10.1007\/s00406-024-01922-9"},{"issue":"5","key":"91324_CR67","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1038\/srep07796","volume":"15","author":"S Ogawa","year":"2015","unstructured":"Ogawa, S. et al. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder. Sci. Rep. 15(5), 7796 (2015).","journal-title":"Sci. Rep."},{"key":"91324_CR68","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/srep00667","volume":"2","author":"R Kaddurah-Daouk","year":"2012","unstructured":"Kaddurah-Daouk, R. et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci. Rep. 2, 667 (2012).","journal-title":"Sci. Rep."},{"issue":"13","key":"91324_CR69","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1017\/S0033291722003233","volume":"53","author":"LA Pan","year":"2023","unstructured":"Pan, L. A. et al. Metabolomic disorders: Confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior. Psychol. Med. 53(13), 6046\u20136054 (2023).","journal-title":"Psychol. Med."},{"issue":"1","key":"91324_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s44192-024-00066-5","volume":"4","author":"J Berner","year":"2024","unstructured":"Berner, J. & Acharjee, A. Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: A pilot study. Discover Mental Health 4(1), 12 (2024).","journal-title":"Discover Mental Health"},{"issue":"1","key":"91324_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41398-022-02000-1","volume":"12","author":"P Shang","year":"2022","unstructured":"Shang, P. et al. Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients. Transl. Psychiatry 12(1), 229 (2022).","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"91324_CR72","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/jcm8060874","volume":"8","author":"HT Lin","year":"2019","unstructured":"Lin, H. T. et al. 1H nuclear magnetic resonance (NMR)-based cerebrospinal fluid and plasma metabolomic analysis in type 2 diabetic patients and risk prediction for diabetic microangiopathy. J. Clin. Med. 8(6), 874 (2019).","journal-title":"J. Clin. Med."},{"issue":"6","key":"91324_CR73","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jhep.2016.07.046","volume":"65","author":"N Weiss","year":"2016","unstructured":"Weiss, N. et al. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. J. Hepatol. 65(6), 1120\u20131130 (2016).","journal-title":"J. Hepatol."},{"issue":"1","key":"91324_CR74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13195-023-01278-7","volume":"15","author":"F Dakterzada","year":"2023","unstructured":"Dakterzada, F. et al. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer\u2019s disease. Alzheimers Res. Ther. 15(1), 134 (2023).","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"91324_CR75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12987-019-0154-5","volume":"16","author":"M Batllori","year":"2019","unstructured":"Batllori, M. et al. Effect of blood contamination of cerebrospinal fluid on amino acids, biogenic amines, pterins and vitamins. Fluids Barriers CNS 16(1), 34 (2019).","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"91324_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1472-6963-3-25","volume":"3","author":"WC Reeves","year":"2003","unstructured":"Reeves, W. C. et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv. Res. 3(1), 25 (2003).","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"91324_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1741-7015-7-57","volume":"7","author":"JF Jones","year":"2009","unstructured":"Jones, J. F. et al. An evaluation of exclusionary medical\/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med. 7(1), 57 (2009).","journal-title":"BMC Med."},{"issue":"5","key":"91324_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PSY.0b013e31819ea179","volume":"71","author":"UM Nater","year":"2009","unstructured":"Nater, U. M. et al. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom. Med. 71(5), 557\u2013565 (2009).","journal-title":"Psychosom. Med."},{"issue":"6","key":"91324_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware, J. E. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6), 473\u2013483 (1992).","journal-title":"Med. Care"},{"issue":"1","key":"91324_CR80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney, C. A., Ware, J. E., Lu, J. F. & Sherbourne, C. D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 32(1), 40\u201366 (1994).","journal-title":"Med. Care"},{"issue":"3","key":"91324_CR81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays, R. D., Sherbourne, C. D. & Mazel, R. M. The RAND 36-Item Health Survey 1.0. Health Econ. 2(3), 217\u2013227 (1993).","journal-title":"Health Econ."},{"issue":"2","key":"91324_CR82","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0033291700030415","volume":"22","author":"G Lewis","year":"1992","unstructured":"Lewis, G., Pelosi, A. J., Araya, R. & Dunn, G. Measuring psychiatric disorder in the community: A standardized assessment for use by lay interviewers. Psychol. Med. 22(2), 465\u2013486 (1992).","journal-title":"Psychol. Med."},{"issue":"2","key":"91324_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37(2), 147\u2013153 (1993).","journal-title":"J. Psychosom. Res."},{"issue":"3","key":"91324_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets, E. M., Garssen, B., Bonke, B. & De Haes, J. C. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39(3), 315\u2013325 (1995).","journal-title":"J. Psychosom. Res."},{"issue":"2","key":"91324_CR85","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack, R. The short-form McGill Pain Questionnaire. Pain 30(2), 191\u2013197 (1987).","journal-title":"Pain"},{"issue":"4","key":"91324_CR86","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1081-1206(10)63129-8","volume":"81","author":"JN Baraniuk","year":"1998","unstructured":"Baraniuk, J. N., Clauw, D. J. & Gaumond, E. Rhinitis symptoms in chronic fatigue syndrome. Ann. Allergy Asthma Immunol. 81(4), 359\u2013365 (1998).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"91324_CR87","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia, 33(9):629\u2013808, (2013).","DOI":"10.1177\/0333102413485658"},{"issue":"2","key":"91324_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1300\/J092v07n02_02","volume":"7","author":"JN Baraniuk","year":"2000","unstructured":"Baraniuk, J. N., Naranch, K., Maibach, H. & Clauw, D. J. Irritant rhinitis in allergic, nonallergic, control and chronic fatigue syndrome populations. J. Chronic Fatigue Syndr. 7(2), 3\u201331 (2000).","journal-title":"J. Chronic Fatigue Syndr."},{"issue":"3\u20134","key":"91324_CR89","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/074823379901500311","volume":"15","author":"CS Miller","year":"1999","unstructured":"Miller, C. S. & Prihoda, T. J. The Environmental Exposure and Sensitivity Inventory (EESI): A standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol. Ind. Health 15(3\u20134), 370\u2013385 (1999).","journal-title":"Toxicol. Ind. Health"},{"issue":"12","key":"91324_CR90","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten, D. M., Suarez, G. A., Low, P. A., Mandrekar, J. & Singer, W. COMPASS 31: A refined and abbreviated composite autonomic symptom score. Mayo Clin. Proc. 87(12), 1196\u20131201 (2012).","journal-title":"Mayo Clin. Proc."},{"issue":"18","key":"91324_CR91","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer, R. L., Kroenke, K. & Williams, J. B. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 282(18), 1737\u20131744 (1999).","journal-title":"JAMA"},{"issue":"5","key":"91324_CR92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O. & L\u00f6we, B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 146(5), 317\u2013325 (2007).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"91324_CR93","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.psychres.2009.03.005","volume":"179","author":"KJ Wardenaar","year":"2010","unstructured":"Wardenaar, K. J. et al. Development and validation of a 30-item short adaptation of the mood and anxiety symptoms questionnaire (MASQ). Psychiatr. Res. 179(1), 101\u2013106 (2010).","journal-title":"Psychiatr. Res."},{"issue":"3","key":"91324_CR94","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.psychres.2007.03.002","volume":"159","author":"KJ Craig","year":"2008","unstructured":"Craig, K. J., Hietanen, H., Markova, I. S. & Berrios, G. E. The irritability questionnaire: A new scale for the measurement of irritability. Psychiatr. Res. 159(3), 367\u2013375 (2008).","journal-title":"Psychiatr. Res."},{"issue":"5","key":"91324_CR95","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/YPG.0000000000000182","volume":"27","author":"J Martin","year":"2017","unstructured":"Martin, J. et al. Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: Comparison of a clinical interview and a self-administered checklist. Psychiatr. Genet. 27(5), 187\u2013196 (2017).","journal-title":"Psychiatr. Genet."},{"issue":"3","key":"91324_CR96","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff, L. S. The CES-D scale. Appl. Psychol. Meas 1(3), 385\u2013401 (1977).","journal-title":"Appl. Psychol. Meas"},{"issue":"2","key":"91324_CR97","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00002508-199706000-00011","volume":"13","author":"ME Geisser","year":"1997","unstructured":"Geisser, M. E., Roth, R. S. & Robinson, M. E. Assessing depression among persons with chronic pain using the Center for epidemiological studies-depression scale and the beck depression inventory: A comparative analysis. Clin. J. Pain 13(2), 163\u2013170 (1997).","journal-title":"Clin. J. Pain"},{"issue":"5","key":"91324_CR98","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1017\/S0033291700037387","volume":"25","author":"R Fuhrer","year":"1995","unstructured":"Fuhrer, R. & Wessely, S. The epidemiology of fatigue and depression: A French primary-care study. Psychol. Med. 25(5), 895\u2013905 (1995).","journal-title":"Psychol. Med."},{"issue":"1","key":"91324_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0304-3959(94)90049-3","volume":"59","author":"DA Williams","year":"1994","unstructured":"Williams, D. A., Robinson, M. E. & Geisser, M. E. Pain beliefs: Assessment and utility. Pain 59(1), 71\u201378 (1994).","journal-title":"Pain"},{"issue":"4","key":"91324_CR100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejpain.2003.10.005","volume":"8","author":"CA Brown","year":"2004","unstructured":"Brown, C. A. The beliefs of people with chronic pain in relation to \u201cimportant\u201d treatment components. Eur. J. Pain 8(4), 325\u2013333 (2004).","journal-title":"Eur. J. Pain"},{"issue":"4","key":"91324_CR101","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan, M. J. L., Bishop, S. R. & Pivik, J. The pain catastrophizing scale: Development and validation. Psychol. Assess. 7(4), 524\u2013532 (1995).","journal-title":"Psychol. Assess."},{"issue":"1","key":"91324_CR102","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(95)00021-J","volume":"63","author":"KO Anderson","year":"1995","unstructured":"Anderson, K. O., Dowds, B. N., Pelletz, R. E., Edwards, T. W. & Peeters-Asdourian, C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain 63(1), 77\u201383 (1995).","journal-title":"Pain"},{"issue":"6","key":"91324_CR103","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jclp.21845","volume":"68","author":"D Conybeare","year":"2012","unstructured":"Conybeare, D., Behar, E., Solomon, A., Newman, M. G. & Borkovec, T. D. The PTSD Checklist-Civilian Version: Reliability, validity, and factor structure in a nonclinical sample. J. Clin. Psychol. 68(6), 699\u2013713 (2012).","journal-title":"J. Clin. Psychol."},{"issue":"5","key":"91324_CR104","first-page":"405","volume":"134","author":"RM Bennett","year":"1981","unstructured":"Bennett, R. M. Fibrositis: Misnomer for a common rheumatic disorder. West J. Med. 134(5), 405\u2013413 (1981).","journal-title":"West J. Med."},{"issue":"5","key":"91324_CR105","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1067\/mhn.2002.129038","volume":"127","author":"K Naranch","year":"2002","unstructured":"Naranch, K. et al. A tender sinus does not always mean rhinosinusitis. Otolaryngol. Head Neck Surg. 127(5), 387\u2013397 (2002).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"1","key":"91324_CR106","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1038\/s41598-020-62771-9","volume":"10","author":"AA Surian","year":"2020","unstructured":"Surian, A. A. & Baraniuk, J. N. Systemic hyperalgesia in females with Gulf War illness, chronic fatigue syndrome and fibromyalgia. Sci. Rep. 10(1), 5751 (2020).","journal-title":"Sci. Rep."},{"issue":"5","key":"91324_CR107","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2214\/ajr.167.5.8911197","volume":"167","author":"JM Prager","year":"1996","unstructured":"Prager, J. M. et al. Spinal headaches after myelograms: Comparison of needle types. AJR Am. J. Roentgenol. 167(5), 1289\u20131292 (1996).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"3","key":"91324_CR108","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/00000542-200209000-00009","volume":"97","author":"ET Riley","year":"2002","unstructured":"Riley, E. T., Hamilton, C. L., Ratner, E. F. & Cohen, S. E. A comparison of the 24-gauge Sprotte and Gertie Marx spinal needles for combined spinal-epidural analgesia during labor. Anesthesiology 97(3), 574\u2013577 (2002).","journal-title":"Anesthesiology"},{"issue":"4","key":"91324_CR109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/gm337","volume":"4","author":"R Mandal","year":"2012","unstructured":"Mandal, R. et al. Multi-platform characterization of the human cerebrospinal fluid metabolome: A comprehensive and quantitative update. Genome Med. 4(4), 38 (2012).","journal-title":"Genome Med."},{"issue":"4","key":"91324_CR110","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-142319","volume":"44","author":"T Koal","year":"2015","unstructured":"Koal, T., Klavins, K., Seppi, D., Kemmler, G. & Humpel, C. Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-\u03b242, tau, and phospho-tau-181 levels. J. Alzheimers Dis. 44(4), 1193\u20131201 (2015).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"91324_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/ijms19010079","volume":"19","author":"AK Cheema","year":"2017","unstructured":"Cheema, A. K. et al. A metabolomic and lipidomic serum signature from nonhuman primates administered with a promising radiation countermeasure, gamma-tocotrienol. Int. J. Mol. Sci. 19(1), 79 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"91324_CR112","first-page":"1","volume":"22","author":"KD Sheikh","year":"2011","unstructured":"Sheikh, K. D., Khanna, S., Byers, S. W., Fornace, A. & Cheema, A. K. Small molecule metabolite extraction strategy for improving LC\/MS detection of cancer cell metabolome. J. Biomol. Tech. 22(1), 1\u20134 (2011).","journal-title":"J. Biomol. Tech."},{"key":"91324_CR113","unstructured":"MetaboAnalyst 6.0 https:\/\/dev.metaboanalyst.ca\/home.xhtml."},{"issue":"W1","key":"91324_CR114","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52(W1), W398-406 (2024).","journal-title":"Nucleic Acids Res."},{"key":"91324_CR115","unstructured":"SPSS - https:\/\/www.ibm.com\/products\/spss-statistics."},{"issue":"2","key":"91324_CR116","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/bioinformatics\/btt633","volume":"30","author":"SM Boca","year":"2014","unstructured":"Boca, S. M., Sinha, R., Cross, A. J., Moore, S. C. & Sampson, J. N. Testing multiple biological mediators simultaneously. Bioinformatics 30(2), 214\u2013220 (2014).","journal-title":"Bioinformatics"},{"issue":"4","key":"91324_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153461","volume":"11","author":"SM Boca","year":"2016","unstructured":"Boca, S. M. et al. Discovery of metabolic biomarkers for duchenne muscular dystrophy within a natural history study. PLoS One 11(4), e0153461 (2016).","journal-title":"PLoS One"},{"key":"91324_CR118","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6035","volume":"6","author":"SM Boca","year":"2018","unstructured":"Boca, S. M. & Leek, J. T. A direct approach to estimating false discovery rates conditional on covariates. PeerJ. 6, e6035 (2018).","journal-title":"PeerJ."},{"issue":"4","key":"91324_CR119","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jrsm.1260","volume":"8","author":"R Suurmond","year":"2017","unstructured":"Suurmond, R., van Rhee, H. & Hak, T. Introduction, comparison, and validation of meta-essentials: A free and simple tool for meta-analysis. Res. Synth. Methods 8(4), 537\u2013553 (2017).","journal-title":"Res. Synth. Methods"},{"key":"91324_CR120","unstructured":"Meta-Essentials [Internet]. Available from: http:\/\/systematicreviewtools.com\/tool.php?ref=Meta-Essentials"},{"key":"91324_CR121","doi-asserted-by":"crossref","unstructured":"Van Rhee, H. J., Suurmond, R. & Hak, T. User manual for Meta-Essentials: Workbooks for meta-analysis (version 1.4), (2015).","DOI":"10.2139\/ssrn.3241355"},{"key":"91324_CR122","unstructured":"Metabocards - https:\/\/hmdb.ca\/metabolites\/HMDB0000479."},{"issue":"D1","key":"91324_CR123","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. HMDB 50: The human metabolome database for 2022. Nucleic Acids Res. 50(D1), D622\u2013D631 (2022).","journal-title":"Nucleic Acids Res."},{"key":"91324_CR124","unstructured":"Baraniuk, J. N. Exertional exhaustion (postexertional malaise, PEM) evaluated by the effects of exercise on cerebrospinal fluid metabolomics, lipidomics and serine pathway in myalgic encephalomyelitis\/chronic fatigue syndrome. International Journal of Molecular Sciences (ISSN 1422-0067, IF 4.9) Manuscript ID: ijms-3366404. Special Issue: Molecular pathologies and treatment for myalgic encephalomyelitis\/chronic fatigue syndrome. Special Issue website: https:\/\/www.mdpi.com\/journal\/ijms\/special_issues\/P7GE9B0370."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91324-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T15:08:31Z","timestamp":1741014511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91324-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91324"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91324-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7381"}}